You can view the latest news of the Company.
 
Select Another Company
 
Market Cap. (Rs.) 113210.78 Cr. P/BV 5.04 Book Value (Rs.) 490.96
52 Week High/Low (Rs.) 2494/1837 FV/ML 2/1 P/E(X) 21.23
Bookclosure 25/07/2025 EPS (Rs.) 116.63 Div Yield (%) 0.73
Date and TimeHeadlines
01/07/2026 21:56 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
01/07/2026 21:53 Lupin - Press Release
01/07/2026 18:23 Lupin - Announcement under Regulation 30 (LODR)-Updates on Acquisition
01/07/2026 18:19 Lupin - General Updates
01/07/2026 16:48 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
01/07/2026 16:44 Lupin - Press Release
30/06/2026 21:17 Lupin - Announcement under Regulation 30 (LODR)-Allotment of ESOP /...
30/06/2026 21:12 Lupin - ESOP/ESOS/ESPS
26/06/2026 16:37 Lupin - Trading Window
26/06/2026 09:39 Lupin - Press Release
26/06/2026 09:37 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
22/06/2026 20:00 Lupin - Announcement under Regulation 30 (LODR)-Allotment of ESOP /...
22/06/2026 19:56 Lupin - ESOP/ESOS/ESPS
17/06/2026 17:08 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
17/06/2026 17:05 Lupin - Press Release
08/06/2026 12:57 Lupin partners with ERN to launch Luforbec Respiratory Therapy in S...
08/06/2026 12:20 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
08/06/2026 12:13 Lupin - Press Release
05/06/2026 10:24 Lupin gets US FDA approval for Ranluspec Biosimilar
04/06/2026 23:06 Lupin - Announcement under Regulation 30 (LODR)-Press Release / Med...
12